Haleon plc (HLN) Stock
HLN Key Statistics
About Haleon plc
Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before officially changing its name to Haleon plc in February 2022. It is headquartered in Brentford, United Kingdom.
CEO: Brian James McNamara. Company website
HLN — Frequently Asked Questions
What is the HLN stock price today?
Haleon plc (HLN) trades at $9.28, down 0.85% on the day, as of Sep 20, 2026 14:57 UTC.
What is Haleon plc's market cap?
Haleon plc has a market capitalisation of $40.87B, calculated from the live HLN share price and shares outstanding.
What is the P/E ratio of HLN?
HLN trades at a trailing P/E of 25.78, from earnings per share of $0.36 over the last twelve months.
How much revenue does Haleon plc make?
Haleon plc generated revenue of $11.16B over the trailing twelve months, which puts the stock at 3.66 times sales.
What is the 52-week range for HLN?
HLN has traded between $8.65 and $11.28 over the past 52 weeks, and the last price is 17.7% below that high.
Is Haleon plc profitable?
Yes. Haleon plc keeps 14.55% of revenue as net income over the trailing twelve months.
What is the analyst price target for HLN?
Wall Street analysts rate HLN Buy, with an average price target of $10.20, 9.9% above the current price.
What sector is Haleon plc in?
Haleon plc is classified under the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry, and is domiciled in GB.
Who is the CEO of Haleon plc?
Brian James McNamara is the chief executive of Haleon plc, which employs 24,535 people.
Where can I track HLN in real time?
QFI Terminal shows HLN with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See HLN live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open HLN in Terminal See plans